Team Uncovers Promising Lead in Genetic Approach to Treating Glioblastoma
Targeted Drug May Aid Pancreatic Cancer Patients With BRCA Mutation
A physician-scientist at the University of Arizona Cancer Center investigated a novel treatment for pancreatic cancer patients whose tumors exhibited a harmful genetic mutation. The results, in which a type of drug called a PARP inhibitor showed early promise in treating pancreatic cancer in patients with mutations in the BRCA gene, were published online last…
